128 related articles for article (PubMed ID: 36870059)
21. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
[TBL] [Abstract][Full Text] [Related]
22. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness.
Yan R; Fan X; Xiao Z; Liu H; Huang X; Liu J; Zhang S; Yao J; An G; Ge Y
Cancer Lett; 2022 Apr; 531():83-97. PubMed ID: 35157971
[TBL] [Abstract][Full Text] [Related]
25. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer.
Inglebert M; Dettwiler M; Hahn K; Letko A; Drogemuller C; Doench J; Brown A; Memari Y; Davies HR; Degasperi A; Nik-Zainal S; Rottenberg S
Sci Rep; 2022 Oct; 12(1):18051. PubMed ID: 36302863
[TBL] [Abstract][Full Text] [Related]
26. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
[TBL] [Abstract][Full Text] [Related]
27. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
28. Tumor organoid biobank-new platform for medical research.
Xie X; Li X; Song W
Sci Rep; 2023 Feb; 13(1):1819. PubMed ID: 36725963
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
Servant R; Garioni M; Vlajnic T; Blind M; Pueschel H; Müller DC; Zellweger T; Templeton AJ; Garofoli A; Maletti S; Piscuoglio S; Rubin MA; Seifert H; Rentsch CA; Bubendorf L; Le Magnen C
J Pathol; 2021 Aug; 254(5):543-555. PubMed ID: 33934365
[TBL] [Abstract][Full Text] [Related]
30. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
31. TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice.
Li A; Zhang C; Gao S; Chen F; Yang C; Luo R; Xiao H
Oncogene; 2013 May; 32(18):2273-81, 2281e.1-12. PubMed ID: 22733137
[TBL] [Abstract][Full Text] [Related]
32. NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.
Yamaguchi T; Yanagisawa K; Sugiyama R; Hosono Y; Shimada Y; Arima C; Kato S; Tomida S; Suzuki M; Osada H; Takahashi T
Cancer Cell; 2012 Mar; 21(3):348-61. PubMed ID: 22439932
[TBL] [Abstract][Full Text] [Related]
33. Wnt/β-catenin signaling is critical for regenerative potential of distal lung epithelial progenitor cells in homeostasis and emphysema.
Hu Y; Ng-Blichfeldt JP; Ota C; Ciminieri C; Ren W; Hiemstra PS; Stolk J; Gosens R; Königshoff M
Stem Cells; 2020 Nov; 38(11):1467-1478. PubMed ID: 32526076
[TBL] [Abstract][Full Text] [Related]
34. Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR.
Isaka T; Yokose T; Ito H; Nakayama H; Miyagi Y; Saito H; Masuda M
BMC Pulm Med; 2021 Mar; 21(1):100. PubMed ID: 33757469
[TBL] [Abstract][Full Text] [Related]
35. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
36. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
[TBL] [Abstract][Full Text] [Related]
37. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Stewart EL; Mascaux C; Pham NA; Sakashita S; Sykes J; Kim L; Yanagawa N; Allo G; Ishizawa K; Wang D; Zhu CQ; Li M; Ng C; Liu N; Pintilie M; Martin P; John T; Jurisica I; Leighl NB; Neel BG; Waddell TK; Shepherd FA; Liu G; Tsao MS
J Clin Oncol; 2015 Aug; 33(22):2472-80. PubMed ID: 26124487
[TBL] [Abstract][Full Text] [Related]
38. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
Ma X; Yang S; Jiang H; Wang Y; Xiang Z
J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
[TBL] [Abstract][Full Text] [Related]
39. Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
Kinehara Y; Nagatomo I; Koyama S; Ito D; Nojima S; Kurebayashi R; Nakanishi Y; Suga Y; Nishijima-Futami Y; Osa A; Nakatani T; Kato Y; Nishide M; Hayama Y; Higashiguchi M; Morimura O; Miyake K; Kang S; Minami T; Hirata H; Iwahori K; Takimoto T; Takamatsu H; Takeda Y; Hosen N; Hoshino S; Shintani Y; Okumura M; Kumagai T; Nishino K; Imamura F; Nakatsuka SI; Kijima T; Kida H; Kumanogoh A
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568033
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination.
Kuo MH; Lee AC; Hsiao SH; Lin SE; Chiu YF; Yang LH; Yu CC; Chiou SH; Huang HN; Ko JC; Chou YT
Cancer Res; 2020 Oct; 80(20):4426-4438. PubMed ID: 32816907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
